Lucy Edwardes Jones

Lucy Edwardes Jones serves as a Board Director at Vianautis, Maxion Therapeutics, ENHANC3D GENOMICS, Elasmogen Ltd, and previously at Pathfinder Medical. Additionally, Lucy holds the position of Investor at BGF since July 2020. Prior experience includes a role as Board Observer at DefiniGEN and various positions at CIL Management Consultants, culminating in a managerial role in healthcare. Lucy's early career featured a brief stint as Assistant Brand Manager at Unilever. Education includes a Bachelor of Arts in History from Durham University and a Master of Science in Russian and East European Studies from the University of Oxford.